Marino Garcia
2023
In 2023, Marino Garcia earned a total compensation of $496K as President and Chief Executive Officer at Dianthus Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $321,159 |
|---|---|
| Salary | $174,863 |
| Total | $496,022 |
Garcia received $321.2K in non-equity incentive plan, accounting for 65% of the total pay in 2023.
Garcia also received $174.9K in salary.
Rankings
In 2023, Marino Garcia's compensation ranked 2,006th out of 2,907 executives tracked by ExecPay. In other words, Garcia earned more than 31.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,006 out of 2,907 | 31st |
Division Manufacturing | 1,142 out of 1,599 | 29th |
Major group Chemicals And Allied Products | 703 out of 901 | 22nd |
Industry group Drugs | 686 out of 864 | 21st |
Industry Pharmaceutical Preparations | 491 out of 622 | 21st |
Source: SEC filing on April 11, 2024.
Garcia's colleagues
We found six more compensation records of executives who worked with Marino Garcia at Dianthus Therapeutics in 2023.
2023
Stephen Mahoney
Dianthus Therapeutics
Former President, Chief Financial and Operating Officer
2023
Thomas Beetham
Dianthus Therapeutics
Chief Legal Officer
2023
Lisa Olson
Dianthus Therapeutics
Chief Scientific Officer
2023
Jason Gardner
Dianthus Therapeutics
Chief Executive Officer
2023
Simrat Randhawa
Dianthus Therapeutics
Chief Medical Officer
2023
Ryan Savitz
Dianthus Therapeutics